Bionical Emas brings life-changing medicines to patients worldwide through Early Access Programs and Clinical Trial Supply services. The company supports pharmaceutical and biotech sponsors with regulatory affairs, pharmacovigilance, medical affairs, global storage, distribution, and project management, ensuring patients gain access to investigational treatments before market approval. Patient centricity drives every decision. Bionical Emas partners with patient advocacy groups, incorporates the patient voice into programme design, and reduces burden on individuals and families navigating clinical trials. The company operates globally, delivering end to end solutions that bridge drug development and patient care.
228
Team Members
1998
Founded
Contract Research
Sector
Hybrid
Work Environment
A world where every patient can access the medicines they need, when they need them, without unnecessary delay or burden.
Empowers patients around the world to gain access to life-changing medicines through Early Access Programs and Clinical Trial Supply services.